Skip to content
Clinical Trials for Alzheimer's Disease

Pennsylvania

Alzheimer's disease clinical trials in Pennsylvania

24 Alzheimer's disease studies are recruiting participants at sites in 5 cities across Pennsylvania as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Pennsylvania by city

Cities with the most studies recruiting right now.

Every Pennsylvania city with a recruiting study

Philadelphia (10), Pittsburgh (10), Plymouth Meeting (4), Abington (1), Butler (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Pennsylvania

Basic details from each study's public record (the 12 most recently updated of 24). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Plymouth Meeting
    Registry record
    NCT07177352 · updated
  2. A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

    • Phase 2
    • Ages 55 to 85
    • All sexes
    Sponsor
    Sanofi
    Recruiting in
    Plymouth Meeting
    Registry record
    NCT07688213 · updated
  3. ACP-204 in Adults With Alzheimer's Disease Psychosis

    • Phase 2/3
    • Ages 55 to 95
    • All sexes
    Sponsor
    ACADIA Pharmaceuticals Inc.
    Recruiting in
    Abington
    Registry record
    NCT06159673 · updated
  4. A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

    • Phase 2
    • Ages 55 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Philadelphia
    Registry record
    NCT07589595 · updated
  5. The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study

    • No phase
    • Ages 55 to 85
    • All sexes
    Sponsor
    California Pacific Medical Center Research Institute
    Recruiting in
    Pittsburgh
    Registry record
    NCT05988385 · updated
  6. A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

    • Phase 2
    • Ages 50 to 85
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Plymouth Meeting
    Registry record
    NCT07033494 · updated
  7. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Plymouth Meeting
    Registry record
    NCT06976203 · updated
  8. Evaluating the Effectiveness of the Health App Recommendation Tool

    • No phase
    • Ages 18 to 65
    • All sexes
    Sponsor
    University of Pittsburgh
    Recruiting in
    Pittsburgh
    Registry record
    NCT07216716 · updated
  9. Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    Celgene
    Recruiting in
    Philadelphia
    Registry record
    NCT06808984 · updated
  10. Dominantly Inherited Alzheimer Network (DIAN)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Recruiting in
    Pittsburgh
    Registry record
    NCT00869817 · updated
  11. PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Pennsylvania
    Recruiting in
    Philadelphia
    Registry record
    NCT05456503 · updated
  12. Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

    • No phase
    • Ages 70 and older
    • All sexes
    Sponsor
    University of Michigan
    Recruiting in
    Philadelphia · Pittsburgh
    Registry record
    NCT05929703 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Pennsylvania on ClinicalTrials.gov.

Ask about studies in Pennsylvania

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call